{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:08:04Z","timestamp":1787162884762,"version":"build-2736575974"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-025-05878-7","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T14:18:01Z","timestamp":1744121881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of salivary nitric oxide levels and anxiety in multiple sclerosis patients, with and without Xerostomia: correlation with clinical variables"],"prefix":"10.1186","volume":"25","author":[{"given":"Aynaz","family":"Khabazian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Koopaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanaz","family":"Khabazian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Manifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Kolahdooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Tafakhori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"issue":"5","key":"5878_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.apjtb.2016.03.009","volume":"6","author":"KMM Koriem","year":"2016","unstructured":"Koriem KMM. Multiple sclerosis: new insights and trends. Asian Pac J Trop Biomed. 2016;6(5):429\u201340.","journal-title":"Asian Pac J Trop Biomed"},{"issue":"10","key":"5878_CR2","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41582-019-0240-y","volume":"15","author":"PM Matthews","year":"2019","unstructured":"Matthews PM. Chronic inflammation in multiple sclerosis\u2014seeing what was always there. Nat Reviews Neurol. 2019;15(10):582\u201393.","journal-title":"Nat Reviews Neurol"},{"issue":"3","key":"5878_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","volume":"18","author":"MT Wallin","year":"2019","unstructured":"Wallin MT, Culpepper WJ, Nichols E, Bhutta ZA, Gebrehiwot TT, Hay SI, Khalil IA, Krohn KJ, Liang X, Naghavi M. Global, regional, and National burden of multiple sclerosis 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(3):269\u201385.","journal-title":"Lancet Neurol"},{"issue":"14","key":"5878_CR4","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van Der Mei I. Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS. Multiple Scler J. 2020;26(14):1816\u201321.","journal-title":"Multiple Scler J"},{"issue":"1","key":"5878_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/08870440903287934","volume":"26","author":"C Bowen","year":"2011","unstructured":"Bowen C, MacLehose A, Beaumont J. Advanced multiple sclerosis and the psychosocial impact on families. Psychol Health. 2011;26(1):113\u201327.","journal-title":"Psychol Health"},{"issue":"11","key":"5878_CR6","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.3390\/ijerph17113979","volume":"17","author":"F Covello","year":"2020","unstructured":"Covello F, Ruoppolo G, Carissimo C, Zumbo G, Ferrara C, Polimeni A, Vozza I. Multiple sclerosis: impact on oral hygiene, dysphagia, and quality of life. Int J Environ Res Public Health. 2020;17(11):3979.","journal-title":"Int J Environ Res Public Health"},{"key":"5878_CR7","doi-asserted-by":"crossref","unstructured":"Manifar S, Najafi S, Koopaie M, Tafakhori A, Farmanbordar D. Assessment of oral health status in chronic headache patients and its comparison with healthy control. J Craniomaxillofacial Res 2021:22\u20138.","DOI":"10.18502\/jcr.v8i1.7153"},{"issue":"3","key":"5878_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/idh.12528","volume":"19","author":"JH Choi","year":"2021","unstructured":"Choi JH, Kim MJ, Kho HS. Oral health-related quality of life and associated factors in patients with Xerostomia. Int J Dental Hygiene. 2021;19(3):313\u201322.","journal-title":"Int J Dental Hygiene"},{"issue":"1","key":"5878_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12903-024-04007-0","volume":"24","author":"M K\u0131ranatl\u0131","year":"2024","unstructured":"K\u0131ranatl\u0131 M, Yurtta\u015f M, G\u00fcng\u00f6r M, Canbaz Kabay S. Evaluation of major salivary glands with ultrasonography in multiple sclerosis patients. BMC Oral Health. 2024;24(1):245.","journal-title":"BMC Oral Health"},{"issue":"1","key":"5878_CR10","first-page":"9","volume":"16","author":"J-K Ku","year":"2023","unstructured":"Ku J-K, Yun P-Y, Jang S, Jung W, Hwang K-G. Clinical guidelines to diagnose and manage dental patients with hyposalivation and Xerostomia. J Korean Dent Sci. 2023;16(1):9\u201322.","journal-title":"J Korean Dent Sci"},{"issue":"2","key":"5878_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/cdoe.12512","volume":"48","author":"N Manchery","year":"2020","unstructured":"Manchery N, Henry JD, Nangle MR. A systematic review of oral health in people with multiple sclerosis. Commun Dent Oral Epidemiol. 2020;48(2):89\u2013100.","journal-title":"Commun Dent Oral Epidemiol"},{"issue":"6","key":"5878_CR12","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s11011-024-01379-8","volume":"39","author":"J Shen","year":"2024","unstructured":"Shen J, Ye Q, Luo F, Yu T, Miao J, Wang W, Yuan H. Causal relationship between multiple sclerosis and primary Sj\u00f6gren\u2019s syndrome: a two-sample Mendelian randomization study. Metab Brain Dis. 2024;39(6):1109\u201315.","journal-title":"Metab Brain Dis"},{"key":"5878_CR13","doi-asserted-by":"publisher","first-page":"103783","DOI":"10.1016\/j.msard.2022.103783","volume":"62","author":"JSI Hora","year":"2022","unstructured":"Hora JSI, da Silva MCR, Braga CLS, Loureiro AM, Alves A, Louren\u00e7o SQC, Vasconcelos CCF. Dry oral and ocular manifestations and autoantibodies characteristic of primary Sj\u00f6gren\u2019s syndrome in multiple sclerosis. Mult Scler Relat Disord. 2022;62:103783.","journal-title":"Mult Scler Relat Disord"},{"issue":"23","key":"5878_CR14","first-page":"4610","volume":"19","author":"GQ Zhang","year":"2015","unstructured":"Zhang GQ, Meng Y. Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider. Eur Rev Med Pharmacol Sci. 2015;19(23):4610\u201320.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"5878_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.joms.2012.05.008","volume":"71","author":"SA Danesh-Sani","year":"2013","unstructured":"Danesh-Sani SA, Rahimdoost A, Soltani M, Ghiyasi M, Haghdoost N, Sabzali-Zanjankhah S. Clinical assessment of orofacial manifestations in 500 patients with multiple sclerosis. J Oral Maxillofac Surg. 2013;71(2):290\u20134.","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"5878_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/adj.12510","volume":"62","author":"N Cockburn","year":"2017","unstructured":"Cockburn N, Pateman K, Taing M, Pradhan A, Ford P. Managing the oral side-effects of medications used to treat multiple sclerosis. Aust Dent J. 2017;62(3):331\u20136.","journal-title":"Aust Dent J"},{"key":"5878_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jprot.2018.07.019","volume":"187","author":"B Manconi","year":"2018","unstructured":"Manconi B, Liori B, Cabras T, Vincenzoni F, Iavarone F, Lorefice L, Cocco E, Castagnola M, Messana I, Olianas A. Top-down proteomic profiling of human saliva in multiple sclerosis patients. J Proteom. 2018;187:212\u201322.","journal-title":"J Proteom"},{"key":"5878_CR18","doi-asserted-by":"publisher","first-page":"117727192110133","DOI":"10.1177\/11772719211013352","volume":"16","author":"A Jafari","year":"2021","unstructured":"Jafari A, Babajani A, Rezaei-Tavirani M. Multiple sclerosis biomarker discoveries by proteomics and metabolomics approaches. Biomark Insights. 2021;16:11772719211013352.","journal-title":"Biomark Insights"},{"issue":"8","key":"5878_CR19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1177\/1535370216638770","volume":"241","author":"S Prasad","year":"2016","unstructured":"Prasad S, Tyagi AK, Aggarwal BB. Detection of inflammatory biomarkers in saliva and urine: potential in diagnosis, prevention, and treatment for chronic diseases. Experimental Biology Med. 2016;241(8):783\u201399.","journal-title":"Experimental Biology Med"},{"key":"5878_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.lfs.2016.02.002","volume":"148","author":"V Rani","year":"2016","unstructured":"Rani V, Deep G, Singh RK, Palle K, Yadav UC. Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci. 2016;148:183\u201393.","journal-title":"Life Sci"},{"issue":"7","key":"5878_CR21","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/brain\/awr128","volume":"134","author":"L Haider","year":"2011","unstructured":"Haider L, Fischer MT, Frischer JM, Bauer J, H\u00f6ftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H. Oxidative damage in multiple sclerosis lesions. Brain. 2011;134(7):1914\u201324.","journal-title":"Brain"},{"issue":"1\u20132","key":"5878_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jns.2012.07.045","volume":"321","author":"SR Oliveira","year":"2012","unstructured":"Oliveira SR, Kallaur AP, Sim\u00e3o ANC, Morimoto HK, Lopes J, Panis C, Petenucci DL, da Silva E, Cecchini R, Kaimen-Maciel DR. Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale. J Neurol Sci. 2012;321(1\u20132):49\u201353.","journal-title":"J Neurol Sci"},{"issue":"1","key":"5878_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1515\/revneuro-2017-0033","volume":"29","author":"M Lan","year":"2017","unstructured":"Lan M, Tang X, Zhang J, Yao Z. Insights in pathogenesis of multiple sclerosis: nitric oxide May induce mitochondrial dysfunction of oligodendrocytes. Rev Neurosci. 2017;29(1):39\u201353.","journal-title":"Rev Neurosci"},{"issue":"1\u20132","key":"5878_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2004.12.008","volume":"231","author":"JP Mostert","year":"2005","unstructured":"Mostert JP, Ramsaransing GS, Heersema DJ, Heerings M, Wilczak N, De Keyser J. Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapses. J Neurol Sci. 2005;231(1\u20132):41\u20134.","journal-title":"J Neurol Sci"},{"issue":"1","key":"5878_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-9-19","volume":"9","author":"G Salemi","year":"2010","unstructured":"Salemi G, Gueli MC, Vitale F, Battaglieri F, Guglielmini E, Ragonese P, Trentacosti A, Massenti MF, Savettieri G, Bono A. Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients. Lipids Health Dis. 2010;9(1):1\u20133.","journal-title":"Lipids Health Dis"},{"issue":"21","key":"5878_CR26","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.3390\/ijms232112725","volume":"23","author":"AV Blagov","year":"2022","unstructured":"Blagov AV, Sukhorukov VN, Orekhov AN, Sazonova MA, Melnichenko AA. Significance of mitochondrial dysfunction in the progression of multiple sclerosis. Int J Mol Sci. 2022;23(21):12725.","journal-title":"Int J Mol Sci"},{"key":"5878_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nbd.2018.01.002","volume":"113","author":"A Mancini","year":"2018","unstructured":"Mancini A, Tantucci M, Mazzocchetti P, de Iure A, Durante V, Macchioni L, Giamp\u00e0 C, Alvino A, Gaetani L, Costa C. Microglial activation and the nitric Oxide\/cGMP\/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis. Neurobiol Dis. 2018;113:97\u2013108.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"5878_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/biology8020037","volume":"8","author":"RM Barcelos IPd, Troxell","year":"2019","unstructured":"Barcelos IPd, Troxell RM, Graves JS. Mitochondrial dysfunction and multiple sclerosis. Biology. 2019;8(2):37.","journal-title":"Biology"},{"issue":"1","key":"5878_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40893-016-0004-0","volume":"1","author":"P Villoslada","year":"2016","unstructured":"Villoslada P. Neuroprotective therapies for multiple sclerosis and other demyelinating diseases. Multiple Scler Demyelinating Disorders. 2016;1(1):1\u201311.","journal-title":"Multiple Scler Demyelinating Disorders"},{"issue":"12","key":"5878_CR30","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","volume":"18","author":"S Faissner","year":"2019","unstructured":"Faissner S, Plemel JR, Gold R, Yong VW. Progressive multiple sclerosis: from pathophysiology to therapeutic strategies. Nat Rev Drug Discovery. 2019;18(12):905\u201322.","journal-title":"Nat Rev Drug Discovery"},{"issue":"13","key":"5878_CR31","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1177\/0022034516673019","volume":"95","author":"X Qu","year":"2016","unstructured":"Qu X, Wu Z, Pang B, Jin L, Qin L, Wang S. From nitrate to nitric oxide: the role of salivary glands and oral bacteria. J Dent Res. 2016;95(13):1452\u20136.","journal-title":"J Dent Res"},{"issue":"1","key":"5878_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/rheumatology\/kep313","volume":"49","author":"PN Correia","year":"2010","unstructured":"Correia PN, Carpenter GH, Paterson KL, Proctor GB. Inducible nitric oxide synthase increases secretion from inflamed salivary glands. Rheumatology. 2010;49(1):48\u201356.","journal-title":"Rheumatology"},{"key":"5878_CR33","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00418-005-0123-8","volume":"125","author":"J Soinila","year":"2006","unstructured":"Soinila J, Nuorva K, Soinila S. Nitric oxide synthase in human salivary glands. Histochem Cell Biol. 2006;125:717\u201323.","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"5878_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/biom11010119","volume":"11","author":"A Klimiuk","year":"2021","unstructured":"Klimiuk A, Zalewska A, Knapp M, Sawicki R, \u0141adny JR, Maciejczyk M. Salivary gland dysfunction in patients with chronic heart failure is aggravated by nitrosative stress, as well as oxidation and glycation of proteins. Biomolecules. 2021;11(1):119.","journal-title":"Biomolecules"},{"key":"5878_CR35","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1007\/s00784-020-03629-2","volume":"24","author":"JO de Farias","year":"2020","unstructured":"de Farias JO, de Freitas Lima SM, Rezende TMB. Physiopathology of nitric oxide in the oral environment and its biotechnological potential for new oral treatments: a literature review. Clin Oral Invest. 2020;24:4197\u2013212.","journal-title":"Clin Oral Invest"},{"issue":"2","key":"5878_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000323953","volume":"36","author":"AK Artemiadis","year":"2011","unstructured":"Artemiadis AK, Anagnostouli MC, Alexopoulos EC. Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology. 2011;36(2):109\u201320.","journal-title":"Neuroepidemiology"},{"issue":"4","key":"5878_CR37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1474-4422(02)00102-3","volume":"1","author":"KJ Smith","year":"2002","unstructured":"Smith KJ, Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 2002;1(4):232\u201341.","journal-title":"Lancet Neurol"},{"issue":"3","key":"5878_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0891-5849(01)00806-1","volume":"32","author":"RM Nagler","year":"2002","unstructured":"Nagler RM, Klein I, Zarzhevsky N, Drigues N, Reznick AZ. Characterization of the differentiated antioxidant profile of human saliva. Free Radic Biol Med. 2002;32(3):268\u201377.","journal-title":"Free Radic Biol Med"},{"key":"5878_CR39","doi-asserted-by":"crossref","unstructured":"Cuevas S, Mayer E, Hughes M, Adler BL, McMahan ZH. Evidence for targeting autonomic dysfunction in systemic sclerosis: A scoping review. J Scleroderma Relat Disorders 2025:23971983241308050.","DOI":"10.1177\/23971983241308050"},{"key":"5878_CR40","doi-asserted-by":"crossref","unstructured":"von B\u00fcltzingsl\u00f6wen I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, Wray D, Brennan MT, Carrozzo M, Gandera B et al. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2007, 103:S57.e51-S57.e15.","DOI":"10.1016\/j.tripleo.2006.11.010"},{"issue":"10","key":"5878_CR41","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00784-024-05913-x","volume":"28","author":"L Lima","year":"2024","unstructured":"Lima L, Gaspar S, Rocha BS, Alves R, Almeida MG. Current clinical framework on nitric oxide role in periodontal disease and blood pressure. Clin Oral Invest. 2024;28(10):521.","journal-title":"Clin Oral Invest"},{"issue":"6","key":"5878_CR42","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/00220345211064571","volume":"101","author":"E Morou-Berm\u00fadez","year":"2022","unstructured":"Morou-Berm\u00fadez E, Torres-Col\u00f3n J, Berm\u00fadez N, Patel R, Joshipura K. Pathways linking oral bacteria, nitric oxide metabolism, and health. J Dent Res. 2022;101(6):623\u201331.","journal-title":"J Dent Res"},{"key":"5878_CR43","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1590\/1807-3107bor-2018.vol32.0082","volume":"32","author":"JSM Humberto","year":"2018","unstructured":"Humberto JSM, Pavanin JV, Rocha M, Motta ACF. Cytokines, cortisol, and nitric oxide as salivary biomarkers in oral lichen planus: a systematic review. Brazilian Oral Res. 2018;32:e82.","journal-title":"Brazilian Oral Res"},{"issue":"1","key":"5878_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.dsx.2019.11.014","volume":"14","author":"P Afsaneh Abadi","year":"2020","unstructured":"Afsaneh Abadi P, Koopaie M, Montazeri R. Comparison of salivary nitric oxide and oral health in diabetic patients with and without Xerostomia. Diabetes Metabolic Syndrome. 2020;14(1):11\u20135.","journal-title":"Diabetes Metabolic Syndrome"},{"issue":"1","key":"5878_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41368-023-00266-9","volume":"16","author":"BT Rosier","year":"2024","unstructured":"Rosier BT, Johnston W, Carda-Di\u00e9guez M, Simpson A, Cabello-Yeves E, Piela K, Reilly R, Artacho A, Easton C, Burleigh M, et al. Nitrate reduction capacity of the oral microbiota is impaired in periodontitis: potential implications for systemic nitric oxide availability. Int J Oral Sci. 2024;16(1):1.","journal-title":"Int J Oral Sci"},{"issue":"1","key":"5878_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/odi.12157","volume":"21","author":"M Hezel","year":"2015","unstructured":"Hezel M, Weitzberg E. The oral Microbiome and nitric oxide homoeostasis. Oral Dis. 2015;21(1):7\u201316.","journal-title":"Oral Dis"},{"key":"5878_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-017-0725-2","volume":"19","author":"NS Bryan","year":"2017","unstructured":"Bryan NS, Tribble G, Angelov N. Oral Microbiome and nitric oxide: the missing link in the management of blood pressure. Curr Hypertens Rep. 2017;19:1\u20138.","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"5878_CR48","doi-asserted-by":"publisher","first-page":"10603","DOI":"10.1038\/s41598-022-14795-6","volume":"12","author":"P Wigner","year":"2022","unstructured":"Wigner P, Dziedzic A, Synowiec E, Miller E, Bijak M, Saluk-Bijak J. Variation of genes encoding nitric oxide synthases and antioxidant enzymes as potential risks of multiple sclerosis development: a preliminary study. Sci Rep. 2022;12(1):10603.","journal-title":"Sci Rep"},{"issue":"20","key":"5878_CR49","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"WM Association","year":"2013","unstructured":"Association WM. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA"},{"issue":"2","key":"5878_CR50","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373.","journal-title":"Lancet Neurol"},{"issue":"1","key":"5878_CR51","first-page":"12","volume":"16","author":"WM Thomson","year":"1999","unstructured":"Thomson WM, Chalmers JM, Spencer AJ, Williams SM. The Xerostomia inventory: a multi-item approach to measuring dry mouth. Community Dent Health. 1999;16(1):12\u20137.","journal-title":"Community Dent Health"},{"issue":"5","key":"5878_CR52","first-page":"3929","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y, Huang X, He F. Mechanism and role of nitric oxide signaling in periodontitis. Experimental Therapeutic Med. 2019;18(5):3929\u201335.","journal-title":"Experimental Therapeutic Med"},{"issue":"6","key":"5878_CR53","first-page":"710","volume":"4","author":"S Panjwani","year":"2013","unstructured":"Panjwani S, Bagewadi A, Keluskar V, Malik R, Rai S, Misra D. Estimation and comparison of levels of salivary nitric oxide in patients with oral lichen planus and controls. Int J Prev Med. 2013;4(6):710\u20134.","journal-title":"Int J Prev Med"},{"issue":"1","key":"5878_CR54","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00784-023-05411-6","volume":"28","author":"H \u00c7evik-Aras","year":"2023","unstructured":"\u00c7evik-Aras H, Musa S, Olofsson R, Almst\u00e5hl A, Almh\u00f6jd U. Patients with oral lichen planus display lower levels of salivary acidic glycoproteins than individuals without oral mucosal disease. Clin Oral Invest. 2023;28(1):2.","journal-title":"Clin Oral Invest"},{"issue":"1","key":"5878_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12903-017-0393-2","volume":"17","author":"KR Larsen","year":"2017","unstructured":"Larsen KR, Johansen JD, Reibel J, Zachariae C, Rosing K, Pedersen AML. Oral symptoms and salivary findings in oral lichen planus, oral lichenoid lesions and stomatitis. BMC Oral Health. 2017;17(1):103.","journal-title":"BMC Oral Health"},{"issue":"4","key":"5878_CR56","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jare.2011.05.005","volume":"2","author":"EH Mobarak","year":"2011","unstructured":"Mobarak EH, Abdallah DM. Saliva nitric oxide levels in relation to caries experience and oral hygiene. J Adv Res. 2011;2(4):357\u201362.","journal-title":"J Adv Res"},{"issue":"4","key":"5878_CR57","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/odi.12952","volume":"25","author":"A Al Hamad","year":"2019","unstructured":"Al Hamad A, Lodi G, Porter S, Fedele S, Mercadante V. Interventions for dry mouth and hyposalivation in Sj\u00f6gren\u2019s syndrome: A systematic review and meta-analysis. Oral Dis. 2019;25(4):1027\u201347.","journal-title":"Oral Dis"},{"issue":"8","key":"5878_CR58","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/odi.12721","volume":"23","author":"G Chamani","year":"2017","unstructured":"Chamani G, Shakibi M, Zarei M, Rad M, Pouyafard A, Parhizkar A, Mansoori M. Assessment of relationship between Xerostomia and oral health-related quality of life in patients with rheumatoid arthritis. Oral Dis. 2017;23(8):1162\u20137.","journal-title":"Oral Dis"},{"issue":"4","key":"5878_CR59","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1600-0560.2009.01368.x","volume":"37","author":"JD Fernandes","year":"2010","unstructured":"Fernandes JD, Nico MMS, Aoki V, Bologna S, Romiti R, Levy-Neto M, Louren\u00e7o SV. Xerostomia in Sj\u00f6gren\u2019s syndrome and lupus erythematosus: a comparative histological and Immunofluorescence study of minor salivary glands alterations. J Cutan Pathol. 2010;37(4):432\u20138.","journal-title":"J Cutan Pathol"},{"key":"5878_CR60","doi-asserted-by":"crossref","unstructured":"Wang MZ, Lehman JS, Rogers RS. Oral signs of vesiculobullous and autoimmune disease. Oral Signs Systemic Disease 2019:113\u201344.","DOI":"10.1007\/978-3-030-10863-2_7"},{"key":"5878_CR61","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00520-014-2477-8","volume":"23","author":"S Hanchanale","year":"2015","unstructured":"Hanchanale S, Adkinson L, Daniel S, Fleming M, Oxberry SG. Systematic literature review: Xerostomia in advanced cancer patients. Support Care Cancer. 2015;23:881\u20138.","journal-title":"Support Care Cancer"},{"issue":"6","key":"5878_CR62","first-page":"550","volume":"109","author":"MJ Kim","year":"2024","unstructured":"Kim MJ, Milliren A, Gerold DJ Jr. Salivary gland disorders: rapid evidence review. Am Family Phys. 2024;109(6):550\u20139.","journal-title":"Am Family Phys"},{"issue":"3","key":"5878_CR63","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3390\/jcm13030707","volume":"13","author":"MP Pecci-Lloret","year":"2024","unstructured":"Pecci-Lloret MP, Linares-P\u00e9rez C, Pecci-Lloret MR, Rodr\u00edguez-Lozano FJ, O\u00f1ate-S\u00e1nchez RE. Oral manifestations in pregnant women: A systematic review. J Clin Med. 2024;13(3):707.","journal-title":"J Clin Med"},{"issue":"5","key":"5878_CR64","first-page":"e586","volume":"22","author":"E Mauri-Obradors","year":"2017","unstructured":"Mauri-Obradors E, Estrugo-Devesa A, Jan\u00e9-Salas E, Vi\u00f1as M, L\u00f3pez-L\u00f3pez J. Oral manifestations of diabetes mellitus. A systematic review. Med Oral Patologia Oral Y Cir Bucal. 2017;22(5):e586\u201394.","journal-title":"Med Oral Patologia Oral Y Cir Bucal"},{"issue":"3","key":"5878_CR65","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4103\/0972-124X.100909","volume":"16","author":"AP Kolte","year":"2012","unstructured":"Kolte AP, Kolte RA, Laddha RK. Effect of smoking on salivary composition and periodontal status. J Indian Soc Periodontology. 2012;16(3):350.","journal-title":"J Indian Soc Periodontology"},{"issue":"3","key":"5878_CR66","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1067\/moe.2001.116814","volume":"92","author":"N Enberg","year":"2001","unstructured":"Enberg N, Alho H, Loimaranta V, Lenander-Lumikari M. Saliva flow rate, amylase activity, and protein and electrolyte concentrations in saliva after acute alcohol consumption. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology. 2001;92(3):292\u20138.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology"},{"key":"5878_CR67","unstructured":"Beck AT, Epstein N, Brown G, Steer R. Beck anxiety inventory. J Consult Clin Psychol 1993."},{"key":"5878_CR68","unstructured":"Kaviani H, Mousavi A. Psychometric properties of the Persian version of Beck anxiety inventory (BAI). Tehran Univ Med J 2008."},{"issue":"12","key":"5878_CR69","first-page":"889","volume":"52","author":"F Askari","year":"2014","unstructured":"Askari F, Ghajarzadeh M, Mohammadifar M, Azimi A, Sahraian MA, Owji M. Anxiety in patients with multiple sclerosis: association with disability, depression, disease type and sex. Acta Medica Iranica. 2014;52(12):889\u201392.","journal-title":"Acta Medica Iranica"},{"key":"5878_CR70","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.msard.2016.10.003","volume":"10","author":"E Butler","year":"2016","unstructured":"Butler E, Matcham F, Chalder T. A systematic review of anxiety amongst people with multiple sclerosis. Multiple Scler Relat Disorders. 2016;10:145\u201368.","journal-title":"Multiple Scler Relat Disorders"},{"issue":"1","key":"5878_CR71","first-page":"7191080","volume":"2020","author":"V Pegoretti","year":"2020","unstructured":"Pegoretti V, Swanson KA, Bethea JR, Probert L, Eisel UL, Fischer R. Inflammation and oxidative stress in multiple sclerosis: consequences for therapy development. Oxidative Med Cell Longev. 2020;2020(1):7191080.","journal-title":"Oxidative Med Cell Longev"},{"key":"5878_CR72","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fncel.2015.00322","volume":"9","author":"JE Yuste","year":"2015","unstructured":"Yuste JE, Tarragon E, Campuzano CM, Ros-Bernal F. Implications of glial nitric oxide in neurodegenerative diseases. Front Cell Neurosci. 2015;9:322.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"5878_CR73","doi-asserted-by":"publisher","first-page":"e1005442","DOI":"10.1371\/journal.ppat.1005442","volume":"12","author":"GC Olivera","year":"2016","unstructured":"Olivera GC, Ren X, Vodnala SK, Lu J, Coppo L, Leepiyasakulchai C, Holmgren A, Kristensson K, Rottenberg ME. Nitric oxide protects against Infection-Induced neuroinflammation by preserving the stability of the Blood-Brain barrier. PLoS Pathog. 2016;12(2):e1005442.","journal-title":"PLoS Pathog"},{"issue":"3","key":"5878_CR74","doi-asserted-by":"publisher","first-page":"e93134","DOI":"10.1371\/journal.pone.0093134","volume":"9","author":"Z Jiang","year":"2014","unstructured":"Jiang Z, Li C, Arrick DM, Yang S, Baluna AE, Sun H. Role of nitric oxide synthases in early blood-brain barrier disruption following transient focal cerebral ischemia. PLoS ONE. 2014;9(3):e93134.","journal-title":"PLoS ONE"},{"key":"5878_CR75","doi-asserted-by":"publisher","first-page":"101873","DOI":"10.1016\/j.msard.2019.101873","volume":"38","author":"M abdel Naseer","year":"2020","unstructured":"abdel Naseer M, Rabah AM, Rashed LA, Hassan A, Fouad AM. Glutamate and nitric oxide as biomarkers for disease activity in patients with multiple sclerosis. Multiple Scler Relat Disorders. 2020;38:101873.","journal-title":"Multiple Scler Relat Disorders"},{"key":"5878_CR76","doi-asserted-by":"publisher","first-page":"101873","DOI":"10.1016\/j.msard.2019.101873","volume":"38","author":"M Abdel Naseer","year":"2020","unstructured":"Abdel Naseer M, Rabah AM, Rashed LA, Hassan A, Fouad AM. Glutamate and nitric oxide as biomarkers for disease activity in patients with multiple sclerosis. Mult Scler Relat Disord. 2020;38:101873.","journal-title":"Mult Scler Relat Disord"},{"key":"5878_CR77","unstructured":"Zhang G-Q, Meng Y. Oral and craniofacial manifestations of multiple sclerosis: implications for the oral health care provider. Eur Rev Med Pharmacol Sci 2015, 19(23)."},{"key":"5878_CR78","doi-asserted-by":"crossref","unstructured":"Hirst DG, Robson T. Nitric oxide physiology and pathology. Nitric Oxide: Methods Protocols 2011:1\u201313.","DOI":"10.1007\/978-1-61737-964-2_1"},{"issue":"2","key":"5878_CR79","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jphs.2015.09.002","volume":"129","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Vanhoutte PM, Leung SW. Vascular nitric oxide: beyond eNOS. J Pharmacol Sci. 2015;129(2):83\u201394.","journal-title":"J Pharmacol Sci"},{"key":"5878_CR80","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.niox.2020.06.004","volume":"102","author":"A Ally","year":"2020","unstructured":"Ally A, Powell I, Ally MM, Chaitoff K, Nauli SM. Role of neuronal nitric oxide synthase on cardiovascular functions in physiological and pathophysiological States. Nitric Oxide. 2020;102:52\u201373.","journal-title":"Nitric Oxide"},{"key":"5878_CR81","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00253-010-2733-x","volume":"88","author":"ML Jones","year":"2010","unstructured":"Jones ML, Ganopolsky JG, Labb\u00e9 A, Wahl C, Prakash S. Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices. Appl Microbiol Biotechnol. 2010;88:401\u20137.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"5878_CR82","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4161\/viru.20328","volume":"3","author":"DO Schairer","year":"2012","unstructured":"Schairer DO, Chouake JS, Nosanchuk JD, Friedman AJ. The potential of nitric oxide releasing therapies as antimicrobial agents. Virulence. 2012;3(3):271\u20139.","journal-title":"Virulence"},{"issue":"4","key":"5878_CR83","first-page":"227","volume":"2004","author":"N Tuteja","year":"2004","unstructured":"Tuteja N, Chandra M, Tuteja R, Misra MK. Nitric oxide as a unique bioactive signaling messenger in physiology and pathophysiology. J Biomed Biotechnol. 2004;2004(4):227\u201337.","journal-title":"J Biomed Biotechnol"},{"key":"5878_CR84","doi-asserted-by":"publisher","first-page":"113862","DOI":"10.1016\/j.bcp.2020.113862","volume":"176","author":"FIF Gomes","year":"2020","unstructured":"Gomes FIF, Cunha FQ, Cunha TM. Peripheral nitric oxide signaling directly blocks inflammatory pain. Biochem Pharmacol. 2020;176:113862.","journal-title":"Biochem Pharmacol"},{"issue":"30","key":"5878_CR85","doi-asserted-by":"publisher","first-page":"2303259","DOI":"10.1002\/advs.202303259","volume":"10","author":"SM Andrabi","year":"2023","unstructured":"Andrabi SM, Sharma NS, Karan A, Shahriar SS, Cordon B, Ma B, Xie J. Nitric oxide: physiological functions, delivery, and biomedical applications. Adv Sci. 2023;10(30):2303259.","journal-title":"Adv Sci"},{"issue":"11","key":"5878_CR86","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.3390\/ijms22115439","volume":"22","author":"EC Wittenborn","year":"2021","unstructured":"Wittenborn EC, Marletta MA. Structural perspectives on the mechanism of soluble guanylate cyclase activation. Int J Mol Sci. 2021;22(11):5439.","journal-title":"Int J Mol Sci"},{"key":"5878_CR87","doi-asserted-by":"crossref","unstructured":"Mollace R, Scarano F, Bava I, Carresi C, Maiuolo J, Tavernese A, Gliozzi M, Musolino V, Muscoli S, Palma E. Modulation of the nitric oxide\/cgmp pathway in cardiac contraction and relaxation: potential role in heart failure treatment. Pharmacol Res 2023:106931.","DOI":"10.1016\/j.phrs.2023.106931"},{"issue":"2","key":"5878_CR88","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2174\/18756190MTA2pMjApy","volume":"19","author":"D Tewari","year":"2021","unstructured":"Tewari D, Sah AN, Bawari S, Nabavi SF, Dehpour AR, Shirooie S, Braidy N, Fiebich BL, Vacca RA, Nabavi SM. Role of nitric oxide in neurodegeneration: function, regulation, and Inhibition. Curr Neuropharmacol. 2021;19(2):114\u201326.","journal-title":"Curr Neuropharmacol"},{"key":"5878_CR89","doi-asserted-by":"publisher","first-page":"118377","DOI":"10.1016\/j.lfs.2020.118377","volume":"259","author":"G Kumar","year":"2020","unstructured":"Kumar G, Dey SK, Kundu S. Functional implications of vascular endothelium in regulation of endothelial nitric oxide synthesis to control blood pressure and cardiac functions. Life Sci. 2020;259:118377.","journal-title":"Life Sci"},{"issue":"20","key":"5878_CR90","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.3390\/ijms21207538","volume":"21","author":"P Pignatelli","year":"2020","unstructured":"Pignatelli P, Fabietti G, Ricci A, Piattelli A, Curia MC. How periodontal disease and presence of nitric oxide reducing oral bacteria can affect blood pressure. Int J Mol Sci. 2020;21(20):7538.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5878_CR91","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3109\/03014460.2013.786756","volume":"40","author":"S AlFadhli","year":"2013","unstructured":"AlFadhli S, Mohammed EM, Al Shubaili A. Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis. Ann Hum Biol. 2013;40(4):368\u201375.","journal-title":"Ann Hum Biol"},{"issue":"1","key":"5878_CR92","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1601-5037.2011.00508.x","volume":"10","author":"S Parwani","year":"2012","unstructured":"Parwani S, Chitnis P, Parwani R. Salivary nitric oxide levels in inflammatory periodontal disease\u2013A case-control and interventional study. Int J Dental Hygiene. 2012;10(1):67\u201373.","journal-title":"Int J Dental Hygiene"},{"key":"5878_CR93","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00011-006-6111-1","volume":"56","author":"M Maniscalco","year":"2007","unstructured":"Maniscalco M, Sofia M, Pelaia G. Nitric oxide in upper airways inflammatory diseases. Inflamm Res. 2007;56:58\u201369.","journal-title":"Inflamm Res"},{"key":"5878_CR94","doi-asserted-by":"crossref","unstructured":"Kallaur AP, Reiche EMV, Oliveira SR, Sim\u00e3o ANC, Pereira WLCJ, Alfieri DF, Flauzino T, Proen\u00e7a CM, Lozovoy MAB, Kaimen-Maciel DR et al. Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis. Molecular Neurobiology 2017, 54(1):31\u201344.","DOI":"10.1007\/s12035-015-9648-6"},{"issue":"3","key":"5878_CR95","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/cdoe.12445","volume":"47","author":"C Sexton","year":"2019","unstructured":"Sexton C, Lalloo R, Stormon N, Pateman K, van der Mei I, Campbell J, Ford P. Oral health and behaviours of people living with multiple sclerosis in Australia. Commun Dent Oral Epidemiol. 2019;47(3):201\u20139.","journal-title":"Commun Dent Oral Epidemiol"},{"issue":"1","key":"5878_CR96","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.dsx.2019.11.014","volume":"14","author":"PA Abadi","year":"2020","unstructured":"Abadi PA, Koopaie M, Montazeri R. Comparison of salivary nitric oxide and oral health in diabetic patients with and without Xerostomia. Diabetes Metabolic Syndrome: Clin Res Reviews. 2020;14(1):11\u20135.","journal-title":"Diabetes Metabolic Syndrome: Clin Res Reviews"},{"issue":"10","key":"5878_CR97","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.3390\/biomedicines12102277","volume":"12","author":"A Kapel-Regu\u0142a","year":"2024","unstructured":"Kapel-Regu\u0142a A, Chojdak-\u0141ukasiewicz J, Rybi\u0144ska A, Du\u015b-Ilnicka I, Radwan-Oczko M. Oral state and salivary cortisol in multiple sclerosis patients. Biomedicines. 2024;12(10):2277.","journal-title":"Biomedicines"},{"key":"5878_CR98","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.mrgentox.2018.11.008","volume":"843","author":"V Borisovs","year":"2019","unstructured":"Borisovs V, \u013beonova E, Baumane L, Kalni\u0146a J, Mjagkova N, Sjakste N. Blood levels of nitric oxide and DNA breaks assayed in whole blood and isolated peripheral blood mononucleated cells in patients with multiple sclerosis. Mutat Research\/Genetic Toxicol Environ Mutagen. 2019;843:90\u20134.","journal-title":"Mutat Research\/Genetic Toxicol Environ Mutagen"},{"issue":"10","key":"5878_CR99","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s40266-018-0588-5","volume":"35","author":"AG Barbe","year":"2018","unstructured":"Barbe AG. Medication-induced Xerostomia and hyposalivation in the elderly: culprits, complications, and management. Drugs Aging. 2018;35(10):877\u201385.","journal-title":"Drugs Aging"},{"issue":"4","key":"5878_CR100","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1034\/j.1601-0825.2003.03967.x","volume":"9","author":"C Scully Cbe","year":"2003","unstructured":"Scully Cbe C. Drug effects on salivary glands: dry mouth. Oral Dis. 2003;9(4):165\u201376.","journal-title":"Oral Dis"},{"key":"5878_CR101","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.archoralbio.2016.03.010","volume":"67","author":"M Johnsson","year":"2016","unstructured":"Johnsson M, Winder M, Zawia H, L\u00f6d\u00f6en I, Tobin G, G\u00f6trick B. In vivo studies of effects of antidepressants on Parotid salivary secretion in the rat. Arch Oral Biol. 2016;67:54\u201360.","journal-title":"Arch Oral Biol"},{"issue":"2","key":"5878_CR102","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1556\/2060.2020.00019","volume":"107","author":"O Einhorn","year":"2020","unstructured":"Einhorn O, Georgiou K, Tompa A. Salivary dysfunction caused by medication usage. Physiol Int. 2020;107(2):195\u2013208.","journal-title":"Physiol Int"},{"key":"5878_CR103","doi-asserted-by":"crossref","unstructured":"Arany S, Kopycka-Kedzierawski DT, Caprio TV, Watson GE. Anticholinergic medication: related dry mouth and effects on the salivary glands. Oral surgery, oral medicine, oral pathology and oral radiology 2021, 132(6):662\u201370.","DOI":"10.1016\/j.oooo.2021.08.015"},{"issue":"10","key":"5878_CR104","doi-asserted-by":"publisher","first-page":"811","DOI":"10.7150\/ijms.12912","volume":"12","author":"J Miranda-Rius","year":"2015","unstructured":"Miranda-Rius J, Brunet-Llobet L, Lahor-Soler E, Farr\u00e9 M. Salivary secretory disorders, inducing drugs, and clinical management. Int J Med Sci. 2015;12(10):811.","journal-title":"Int J Med Sci"},{"issue":"3","key":"5878_CR105","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.tripleo.2009.05.047","volume":"108","author":"DJ Fischer","year":"2009","unstructured":"Fischer DJ, Epstein JB, Klasser G. Multiple sclerosis: an update for oral health care providers. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology. 2009;108(3):318\u201327.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology"},{"key":"5878_CR106","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.bbi.2020.04.078","volume":"88","author":"YZ Szabo","year":"2020","unstructured":"Szabo YZ, Slavish DC, Graham-Engeland JE. The effect of acute stress on salivary markers of inflammation: A systematic review and meta-analysis. Brain Behav Immun. 2020;88:887\u2013900.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"5878_CR107","doi-asserted-by":"publisher","first-page":"e0282740","DOI":"10.1371\/journal.pone.0282740","volume":"18","author":"I Morita","year":"2023","unstructured":"Morita I, Morioka H, Abe Y, Nomura T, Nakashima S, Sugiura I, Inagawa Y, Kondo Y, Kameyama C, Kondo K, et al. Discordance between hyposalivation and Xerostomia among community-dwelling older adults in Japan. PLoS ONE. 2023;18(3):e0282740.","journal-title":"PLoS ONE"},{"issue":"2","key":"5878_CR108","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5213\/inj.2012.16.2.86","volume":"16","author":"AM Murphy","year":"2012","unstructured":"Murphy AM, Bethoux F, Stough D, Goldman HB. Prevalence of stress urinary incontinence in women with multiple sclerosis. Int Neurourol J. 2012;16(2):86\u201390.","journal-title":"Int Neurourol J"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-05878-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-025-05878-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-05878-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:17:14Z","timestamp":1744204634000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-025-05878-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5878"],"URL":"https:\/\/doi.org\/10.1186\/s12903-025-05878-7","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Tehran University of Medical Sciences Ethical Committee (Ethical code: IR.TUMS.DENTISTRY.REC.1400.185). After the study objectives were described, all the participants signed informed consent before participating in this study. All methods were performed in accordance with the relevant guidelines and regulations and all methods were performed in accordance with the Declaration of Helsinki [\n                      \n                      ].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"https:\/\/ethics.research.ac.ir\/ProposalCertificateEn.php? id=240623&Print=true&NoPrintHeader=true&NoPrintFooter=true&NoPrintPageBorder=true&LetterPrint=true.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Online version"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"507"}}